ClinicalTrials.gov
public full text
Public Domain
Estradiol-mediated Inflammation and Central Sensitization in the Pathophysiology of Endometriosis-associated Pelvic Pain
The purpose of this study is to better understand how hormone suppression with Relugolix Combination-Therapy (CT) affects pelvic pain, inflammation, and pain sensitivity in women with moderate-to-severe endometriosis associated pelvic pain.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Relugolix for Endometriosis Associated Pain#1140530
- A Call for New Theories on the Pathogenesis and Pathophysiology of Endometriosis#250591
- The Influence of Central Sensitization in Endometriosis Disease#872840
- Genomic Maps of Endometrial Tissues of Patients With Endometriosis and Healthy Controls#862509
- An Overview of Endometriosis and Potential Pharmacogenetic Targets#233290
Record · ID 1352333
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive